Luigi Mangione pleads guilty in federal case, admits he killed US insurance CEO

Luigi Mangione has pleaded guilty in a federal case to the fatal shooting of Brian Thompson, the chief executive of UnitedHealthcare, according to court documents filed on Friday. Mangione admitted to intentionally killing Thompson, who was shot outside a midtown Manhattan hotel on December 4, 2024, during an investor conference. The plea comes as part of a broader legal battle involving both federal and state charges against Mangione, who is facing potential life imprisonment under the terms of the agreement. The guilty plea was made during a court appearance before US District Judge Margaret Garnett, who confirmed that Mangione's sentence will be determined on December 18. If convicted, Mangione could have faced life imprisonment for each of the two federal charges, stalking with intent to kill and attempted murder. Prosecutors, including Jamie McDonald, the Manhattan US Attorney, have indicated they will push for the maximum penalty, recommending a life sentence. This outcome follows months of legal maneuvering, including multiple attempts at reaching a plea deal between prosecutors and Mangione’s defense team. Mangione, 28, was arrested shortly after the shooting and has been held in custody since. His admission marks a significant shift in the case, which initially drew national attention due to the brazen nature of the attack and its symbolic implications regarding public frustration with healthcare costs and corporate practices. The incident sparked widespread condemnation from political leaders and media outlets, with many viewing it as a reflection of deeper societal tensions. Prior to this week’s plea, Mangione’s legal team had engaged in several rounds of negotiations with federal prosecutors. These discussions began in late June, though they ultimately failed to produce a binding agreement. A second round of talks reportedly took place in early September, but again, no resolution was reached. Despite these setbacks, Mangione and his attorneys opted to proceed with the plea, likely to avoid a lengthy and potentially more severe trial process. The case involves both federal and state jurisdictions, with New York State prosecutors also pursuing charges against Mangione. By pleading guilty to federal charges, Mangione may be able to secure the dismissal of some state-level criminal charges, thereby reducing the number of cases he must face. However, the exact impact of the plea on the state prosecution remains unclear, as the two legal systems operate independently. In the days leading up to the plea, public interest in the case remained high, with protests and vigils organized in response to Thompson’s death. Supporters of Mangione, including members of his family and certain advocacy groups, have expressed concern over the severity of the proposed sentence, arguing that the circumstances surrounding the shooting warrant a more lenient approach. Meanwhile, critics of the healthcare system have used the case to highlight ongoing issues within the industry, suggesting that such acts of violence reflect a broader sense of disillusionment among the public. As the legal proceedings move forward, the focus will remain on the sentencing hearing scheduled for December 18. At that time, Judge Garnett will determine whether Mangione receives the recommended life sentence or if other factors might influence the final decision. Regardless of the outcome, the case is expected to continue generating significant public and political discourse, particularly given its intersection with broader debates over healthcare policy and corporate accountability.